Novyra Information

Novyra is transforming how clinicians and healthcare professionals connect cancer patients with clinical trials. Today, thousands of potentially life-saving studies remain under-enrolled, while patients especially in underserved regions struggle to access the latest therapies. Novyra bridges this gap with an AI-driven platform built in collaboration with oncological experts, designed to make trial matching fast, accurate, and clinician-friendly. Our platform simplifies the complexity of clinical trial protocols by: * AI-Powered Matching: Quickly align patients with relevant trials based on medical history, eligibility criteria, and geography. * Clinician-First Design: Provide oncologists, radiologists, nurses, and trial directors with intuitive tools that integrate into real-world workflows. * On-Demand Insights: An embedded chatbot helps answer protocol queries instantly, reducing time spent navigating dense documents. We serve U.S. regional oncologists, international cancer centers, clinical trial directors, payers, and advocacy groups who share our mission: accelerating access to cutting-edge treatments for every patient, everywhere. Currently in beta, Novyra is working closely with early partners to refine and expand the platform’s capabilities. Together, we aim to reshape the trial ecosystem unlocking efficiency for researchers, reducing costs for sponsors, and most importantly, giving patients more timely options for care. 🔹 Our Mission: Deliver smarter trial matching that shortens enrollment timelines and expands patient access. 🔹 Our Vision: A future where no patient misses the opportunity to participate in a life-changing trial.